| Product Code: ETC9003654 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Russia Spinal Muscular Atrophy Treatment Market Overview |
3.1 Russia Country Macro Economic Indicators |
3.2 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Russia Spinal Muscular Atrophy Treatment Market - Industry Life Cycle |
3.4 Russia Spinal Muscular Atrophy Treatment Market - Porter's Five Forces |
3.5 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume Share, By TreatmentTreatment, 2021 & 2031F |
3.7 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume Share, By TreatmentDrug, 2021 & 2031F |
3.8 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Russia Spinal Muscular Atrophy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of spinal muscular atrophy in Russia |
4.2.2 Advances in medical research leading to the development of innovative treatments |
4.2.3 Growing healthcare infrastructure and government initiatives to improve access to treatment |
4.3 Market Restraints |
4.3.1 High cost of spinal muscular atrophy treatments leading to limited affordability |
4.3.2 Limited availability of specialized healthcare professionals for SMA treatment in Russia |
5 Russia Spinal Muscular Atrophy Treatment Market Trends |
6 Russia Spinal Muscular Atrophy Treatment Market, By Types |
6.1 Russia Spinal Muscular Atrophy Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Type 1, 2021- 2031F |
6.1.4 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Type 2, 2021- 2031F |
6.1.5 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Type 3, 2021- 2031F |
6.1.6 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Type 4, 2021- 2031F |
6.2 Russia Spinal Muscular Atrophy Treatment Market, By TreatmentTreatment |
6.2.1 Overview and Analysis |
6.2.2 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2.3 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Drug, 2021- 2031F |
6.3 Russia Spinal Muscular Atrophy Treatment Market, By TreatmentDrug |
6.3.1 Overview and Analysis |
6.3.2 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Spinraza, 2021- 2031F |
6.3.3 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Zolgensma (AVXS-101), 2021- 2031F |
6.3.4 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Evrysdi, 2021- 2031F |
6.3.5 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Russia Spinal Muscular Atrophy Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Russia Spinal Muscular Atrophy Treatment Market Revenues & Volume, By Injection, 2021- 2031F |
7 Russia Spinal Muscular Atrophy Treatment Market Import-Export Trade Statistics |
7.1 Russia Spinal Muscular Atrophy Treatment Market Export to Major Countries |
7.2 Russia Spinal Muscular Atrophy Treatment Market Imports from Major Countries |
8 Russia Spinal Muscular Atrophy Treatment Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for SMA treatments |
8.2 Number of treatment centers specializing in SMA in Russia |
8.3 Government funding allocated to SMA research and treatment |
8.4 Rate of adoption of new SMA treatment guidelines by healthcare providers |
9 Russia Spinal Muscular Atrophy Treatment Market - Opportunity Assessment |
9.1 Russia Spinal Muscular Atrophy Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Russia Spinal Muscular Atrophy Treatment Market Opportunity Assessment, By TreatmentTreatment, 2021 & 2031F |
9.3 Russia Spinal Muscular Atrophy Treatment Market Opportunity Assessment, By TreatmentDrug, 2021 & 2031F |
9.4 Russia Spinal Muscular Atrophy Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Russia Spinal Muscular Atrophy Treatment Market - Competitive Landscape |
10.1 Russia Spinal Muscular Atrophy Treatment Market Revenue Share, By Companies, 2024 |
10.2 Russia Spinal Muscular Atrophy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |